Argus Investors Counsel Inc. grew its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 10.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,581 shares of the company’s stock after buying an additional 740 shares during the quarter. Eli Lilly […]